Evidence map›Paper›PMID 32281225›Full record

ArticleCNS neuroscience & therapeutics2020

Epidermal neural crest stem cell transplantation as a promising therapeutic strategy for ischemic stroke.

Mohammad Saied Salehi, Sareh Pandamooz, Anahid Safari, Benjamin Jurek, Amin Tamadon, Mohammad Reza Namavar, Mehdi Dianatpour, Leila Dargahi, Negar Azarpira, Sadegh Fattahi and 9 more

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Brain repair mechanisms after cell therapy for stroke.Brain : a journal of neurology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Mohammad Saied SalehiClinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sareh PandamoozNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Anahid SafariStem cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Benjamin JurekDepartment of Behavioral and Molecular Neurobiology, Faculty of Biology and Preclinical Medicine, University of Regensburg, Regensburg, Germany.
Amin TamadonThe Persian Gulf Marine Biotechnology Research Center, Bushehr University of Medical Sciences, Bushehr, Iran.
Mohammad Reza NamavarClinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mehdi DianatpourStem cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Leila DargahiNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Negar AzarpiraTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sadegh FattahiCellular & Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Seyed Mostafa Shid MoosaviDepartment of Physiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Somaye KeshavarzDepartment of Physiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Zahra KhodabandehStem cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Shahrokh ZareStem cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Somayeh NazariDepartment of Physiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mojdeh HeidariTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sadegh IzadiClinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Maryam PoursadeghfardClinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Afshin Borhani-HaghighiClinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0002-4131-7990
Shiraz University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRBabol University of Medical Sciences · IRBiotechnology Research Center · IRUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCell-based therapy is considered as promising strategy to cure stroke. However, employing appropriate type of stem cell to fulfill many therapeutic needs of cerebral ischemia is still challenging. In this regard, the current study was designed to elucidate therapeutic potential of epidermal neural crest stem cells (EPI-NCSCs) compared to bone marrow mesenchymal stem cells (BM-MSCs) in rat model of ischemic stroke.

methodsIschemic stroke was induced by middle cerebral artery occlusion (MCAO) for 45 minutes. Immediately after reperfusion, EPI-NCSCs or BM-MSCs were transplanted via intra-arterial or intravenous route. A test for neurological function was performed before ischemia and 1, 3, and 7 days after MCAO. Also, infarct volume ratio and relative expression of 15 selected target genes were evaluated 7 days after transplantation.

resultsEPI-NCSCs transplantation (both intra-arterial and intravenous) and BM-MSCs transplantation (only intra-arterial) tended to result in a better functional outcome, compared to the MCAO group; however, this difference was not statistically significant. The infarct volume ratio significantly decreased in NCSC-intra-arterial, NCSC-intravenous and MSC-intra-arterial groups compared to the control. EPI-NCSCs interventions led to higher expression levels of Bdnf, nestin, Sox10, doublecortin, β-III tubulin, Gfap, and interleukin-6, whereas neurotrophin-3 and interleukin-10 were decreased. On the other hand, BM-MSCs therapy resulted in upregulation of Gdnf, β-III tubulin, and Gfap and down-regulation of neurotrophin-3, interleukin-1, and interleukin-10.

conclusionThese findings highlight the therapeutic effects of EPI-NCSCs transplantation, probably through simultaneous induction of neuronal and glial formation, as well as Bdnf over-expression in a rat model of ischemic stroke.

Indexed as

AnimalsBrain IschemiaDoublecortin ProteinEpidermal CellsIschemic StrokeMaleNeural CrestNeural Stem CellsRatsRats, Sprague-DawleyStem Cell TransplantationDoublecortin Proteinbone marrow mesenchymal stem cellscell therapycerebral ischemiaepidermal neural crest stem cellsInfarct volumeneurological deficits

Identifiers

PMID32281225
PMCPMC7298983
OpenAlexW3016185236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.